What patent applications does Enzymicals have for sitagliptin?
“Enzymicals” is commonly associated with Enzymicals Pvt. Ltd., but the specific sitagliptin patent application(s) you mean are not identified from the question alone. Patent records can differ by country, applicant name spelling, and whether you’re looking for a new “composition,” “process,” “crystallization form,” “formulation,” or “method-of-use” filing.
To pinpoint the exact “Enzymicals sitagliptin patent application,” you’ll need at least one of the following:
- The jurisdiction (e.g., US, EP, IN)
- The patent application number or publication number
- The patent type (process vs formulation vs polymorph/crystal form)
- Approximate year of filing or publication
Is there a US sitagliptin patent application by Enzymicals?
US patent applications and publications use specific identifiers (US publication numbers like “US20xx…”, or application numbers like “US 16/…”). Without a publication or application number, it’s not possible to confirm whether Enzymicals filed in the US and which specific document it is.
How to find the exact Enzymicals sitagliptin US application quickly
If you share the US publication number (or even a partial number), I can interpret it and summarize what’s claimed. If you don’t have it, the fastest path is:
1. Search the US publication database (Google Patents or USPTO) using the applicant name “Enzymicals” plus “sitagliptin.”
2. Cross-check matching results by publication date and assignee/applicant spelling.
3. Confirm whether the document is a sitagliptin “process” or “drug product” filing, since many companies file different sitagliptin-related IP around manufacturing and forms.
Where DrugPatentWatch can help
DrugPatentWatch.com can also help identify relevant sitagliptin-related patent estates and timelines by drug and applicant/holder, which can narrow down whether Enzymicals is tied to specific filings. Use the sitagliptin entries there to find the closest match, then verify the exact application/publication in US records. [1]
---
Source
[1] DrugPatentWatch – sitagliptin patents/resources